Chronic viral hepatitis affect hundreds of millions of people worldwide, and each year millions more people become infected. In Chronic Viral Hepatitis, Second Edition, a panel of distinguished clinicians and clinical investigators build upon the first edition by comprehensively reviewing all the relevant new information regarding resistance, side effects, and therapies for chronic viral hepatitis. The text covers recent advances in the understanding of pathogenesis of viral hepatitis while discussing promising agents in development for its treatment. The authors devote special attention to reactivation of hepatitis B with chemotherapy and immunosuppression, herbal and non-traditional therapies, chronic viral hepatitis in the pediatric population, and immunology and immunotherapy of HCV and provide relative costs for all diagnostic and therapeutic options. Authoritative and up-to-date, Chronic Viral Hepatitis, Second Edition offers today's gastroenterologists, internists, hepatologists, and infectious disease specialists a practical guide to the recognition, diagnosis and treatment of chronic viral hepatitis from a multidisciplinary approach. TOC:1. Molecular Biology of HCV and HBV. 2. HCV Epidemiology, risk factors and natural history. 3. Current and Future Therapy of HCV. 4. Hepatitis C in Special Populations. 5. Extrahepatic Manifestations of HCV. 6. Anti-HCV Agents in Development. 7. HBV Epidemiology, screening and natural history. 8. Current treatment of Chronic Hepatitis B. 9. HBV and HIV Coinfection. 10. Management of Antiviral Resistance in Chronic Hepatitis B. 11. Herbal therapies for viral hepatitis. 12. HBV Reactivation. 13. Patient support during therapy. 14. Viral hepatitis, A through E, in pregnancy. 15. Chronic viral hepatitis and liver transplantation. 16. Chronic viral hepatitis in the pediatric population. 17. Viral Hepatitis and Hepatocellular Carcinoma. 18. Vaccines and prevention of chronic hepatitis. 19. The immunology and immunotherapy of chronic HCV. In Chronic Viral Hepatitis, Second Edition, a panel of distinguished clinicians and clinical investigators build upon the first edition by comprehensively reviewing all the relevant new information regarding resistance, side effects, and therapies for chronic viral hepatitis.